191 related articles for article (PubMed ID: 26535983)
21. Uterine adenosarcoma with ovarian sex cord-like differentiation: a case report and review of the literature.
Ulker V; Yavuz E; Gedikbasi A; Numanoglu C; Sudolmus S; Gulkilik A
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):518-21. PubMed ID: 22212329
[TBL] [Abstract][Full Text] [Related]
22. Uterine müllerian adenosarcoma with sarcomatous overgrowth and lung metastasis in a 25-year-old woman.
Choi YJ; Jung MH; Park YK; Lee BY; Huh CY
Eur J Gynaecol Oncol; 2011; 32(1):91-4. PubMed ID: 21446335
[TBL] [Abstract][Full Text] [Related]
23. Müllerian adenosarcoma of the uterus with low-grade sarcomatous overgrowth characterized by prominent hydropic change resulting in mimicry of a smooth muscle tumor.
Wu RI; Schorge JO; Dal Cin P; Young RH; Oliva E
Int J Gynecol Pathol; 2014 Nov; 33(6):573-80. PubMed ID: 25272296
[TBL] [Abstract][Full Text] [Related]
24. Clinical management of uterine cervical mullerian adenosarcoma: A clinicopathological study of six cases and review of the literature.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):479-482. PubMed ID: 30122564
[TBL] [Abstract][Full Text] [Related]
25. Müllerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases.
Clement PB
Am J Surg Pathol; 1989 Jan; 13(1):28-38. PubMed ID: 2535774
[TBL] [Abstract][Full Text] [Related]
26. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
[TBL] [Abstract][Full Text] [Related]
27. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract][Full Text] [Related]
28. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
[TBL] [Abstract][Full Text] [Related]
29. Uterine Adenosarcoma.
Ulrich UA; Denschlag D
Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
[TBL] [Abstract][Full Text] [Related]
30. Low grade Mullerian adenosarcoma of pouch of Douglas recurring as bilateral ovarian high grade Mullerian adenosarcoma with rhabdomyosarcomatous overgrowth after 11 years.
Kumar S; Raza M; Tariq MU
J Pak Med Assoc; 2018 Aug; 68(8):1263-1266. PubMed ID: 30108400
[TBL] [Abstract][Full Text] [Related]
31. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
Hum Pathol; 2024 Jun; 148():14-22. PubMed ID: 38688412
[TBL] [Abstract][Full Text] [Related]
32. Primary vaginal adenosarcoma with sarcomatous overgrowth.
Toyoshima M; Akahira J; Moriya T; Hayakawa S; Yaegashi N
Gynecol Oncol; 2004 Dec; 95(3):759-61. PubMed ID: 15582000
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological spectrum of 19 adenosarcomas of female genital tract, including uncommon clinical associations and immunohistochemical profile, reviewed at a single institution.
Rekhi B; Deodhar KK; Maheshwari A; Menon S; Kerkar R; Bajpai J; Ghosh J; Gupta S; Engineer R; Shrivastava SK
Indian J Pathol Microbiol; 2012; 55(3):326-32. PubMed ID: 23032825
[TBL] [Abstract][Full Text] [Related]
34. Müllerian adenosarcoma with ovarian sex cord-like differentiation. A light- and electron-microscopic study.
Hirschfield L; Kahn LB; Chen S; Winkler B; Rosenberg S
Cancer; 1986 Mar; 57(6):1197-200. PubMed ID: 3002598
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
Seidman JD; Chauhan S
Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
37. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
38. [High-grade sarcoma with areas of mullerian adenosarcoma of the uterus].
Zanotti F; Mussida M; Merlo D; Milesi M; Aletti L
Ann Ostet Ginecol Med Perinat; 1991; 112(1):29-35. PubMed ID: 1656835
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
40. Müllerian adenosarcoma presenting as cervical polyps: a report of seven cases and review of the literature.
Kerner H; Lichtig C
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):655-9. PubMed ID: 8385764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
